Minimally invasive glaucoma surgical instrument and method
US-9226850-B2 · Jan 5, 2016 · US
US12551376B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12551376-B2 |
| Application number | US-202217866429-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 15, 2022 |
| Priority date | Jun 26, 2006 |
| Publication date | Feb 17, 2026 |
| Grant date | Feb 17, 2026 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Devices, methods and kits are described for reducing intraocular pressure. The devices include a support that is implantable within Schlemm's canal and maintains the patency of the canal without substantially interfering with transmural fluid flow across the canal. The devices utilize the natural drainage process of the eye and can be implanted with minimal trauma to the eye. Kits include a support and an introducer for implanting the support within Schlemm's canal. Methods include implanting a support within Schlemm's canal, wherein the support is capable of maintaining the patency of the canal without substantial interference with transmural fluid flow across the canal.
Opening claim text (preview).
The invention claimed is: 1 . A kit for reducing intraocular pressure, comprising: a support configured to be implanted circumferentially within Schlemm's canal to maintain patency of at least a portion of Schlemm's canal; an introducer configured to position the support within Schlemm's canal; and a dilating device configured to inject fluid into Schlemm's canal. 2 . The kit of claim 1 , wherein the support is configured to allow transmural fluid flow across Schlemm's canal. 3 . The kit of claim 1 , wherein the support comprises an arcuate member. 4 . The kit of claim 3 , wherein the arcuate member comprises a radius of curvature of about 3 mm to about 8 mm. 5 . The kit of claim 3 , wherein the arcuate member comprises a radius of curvature that is smaller than a radius of curvature of Schlemm's canal. 6 . The kit of claim 1 , wherein the support is configured to extend about one quarter of the way around Schlemm's canal. 7 . The kit of claim 1 , wherein the support is configured to extend about one half of the way around Schlemm's canal. 8 . The kit of claim 1 , wherein the support comprises at least one fenestration. 9 . The kit of claim 8 , wherein the support comprises a plurality of fenestrations. 10 . The kit of claim 1 , wherein the support is non-tubular. 11 . The kit of claim 1 , wherein the support comprises a shape memory material. 12 . The kit of claim 1 , wherein the support is a first support, the kit further comprising at least one second support. 13 . The kit of claim 12 , wherein the first support and the at least one second support are configured to be implanted within different eyes of a patient. 14 . The kit of claim 1 , wherein the introducer comprises a cannula configured to guide the support to Schlemm's canal. 15 . The kit of claim 14 , wherein the cannula is tubular. 16 . The kit of claim 14 , wherein the introducer further comprises a rod configured to advance the support into Schlemm's canal. 17 . The kit of claim 16 , wherein the rod is positioned within a lumen of the cannula. 18 . The kit of claim 17 , wherein the support is positioned at distal end of the rod within the lumen of the cannula. 19 . The kit of claim 1 , wherein the fluid comprises a high viscosity fluid. 20 . The kit of claim 19 , wherein the fluid comprises sodium hyaluronate.
implantable in, or in contact with, the eye, e.g. ocular inserts · CPC title
Means for introducing or releasing pharmaceutical products into the body · CPC title
using shape memory or superelastic materials, e.g. nitinol · CPC title
bioabsorbable · CPC title
Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment (drainage implants in general A61M27/002) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.